SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2qym'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FAP_A_RAPA108_2 (FK506-BINDING PROTEIN FRAP)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	4 / 8	LEU A 234 ARG A 238 PHE A 204 GLY A 205	None	0.87A	1fapB-2qymA: undetectable	1fapB-2qymA: 16.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1G5Y_B_9CRB501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 12	ILE A 243 ALA A 291 LEU A 298 LEU A 253 ILE A 247	None	1.24A	1g5yB-2qymA: undetectable	1g5yB-2qymA: 25.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GSE_A_EAAA224_1 (GLUTATHIONE TRANSFERASE)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 12	ARG A 251 LEU A 313 LEU A 382 VAL A 386 ALA A 320	None	0.97A	1gseA-2qymA: undetectable	1gseA-2qymA: 22.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 12	TYR A 281 ASN A 443 THR A 455 ILE A 458 MET A 459	None	0.81A	1xlxA-2qymA: 43.2	1xlxA-2qymA: 75.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	9 / 12	TYR A 281 HIS A 282 HIS A 326 MET A 395 LEU A 441 ASN A 443 THR A 455 ILE A 458 PHE A 494	None	0.50A	1xlxA-2qymA: 43.2	1xlxA-2qymA: 75.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	7 / 12	TYR A 281 HIS A 282 HIS A 326 MET A 395 THR A 455 ILE A 458 PHE A 494	None	0.47A	1xlxB-2qymA: 43.4	1xlxB-2qymA: 75.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XMU_A_ROFA101_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	9 / 12	TYR A 281 HIS A 282 ASP A 440 LEU A 441 PRO A 444 TYR A 451 TRP A 454 ILE A 458 PHE A 494	None None ZN A 1 (-2.5A) None None None None None None	0.59A	1xmuA-2qymA: 44.0	1xmuA-2qymA: 75.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XMU_B_ROFB102_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	9 / 12	TYR A 281 HIS A 282 MET A 395 ASP A 440 LEU A 441 PRO A 444 TYR A 451 TRP A 454 ILE A 458	None None None ZN A 1 (-2.5A) None None None None None	0.54A	1xmuB-2qymA: 43.4	1xmuB-2qymA: 75.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	7 / 12	TYR A 281 HIS A 282 MET A 395 ASP A 440 LEU A 441 ILE A 458 PHE A 494	None None None ZN A 1 (-2.5A) None None None	0.44A	1xomA-2qymA: 43.7	1xomA-2qymA: 82.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	7 / 12	TYR A 281 HIS A 282 MET A 395 LEU A 441 THR A 455 ILE A 458 PHE A 494	None	0.46A	1xomB-2qymA: 43.6	1xomB-2qymA: 82.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOQ_A_ROFA502_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	10 / 12	TYR A 281 HIS A 282 MET A 395 ASP A 440 LEU A 441 PRO A 444 TYR A 451 THR A 455 ILE A 458 PHE A 494	None None None ZN A 1 (-2.5A) None None None None None None	0.60A	1xoqA-2qymA: 43.9	1xoqA-2qymA: 82.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOQ_B_ROFB501_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	10 / 12	TYR A 281 HIS A 282 ASP A 440 LEU A 441 PRO A 444 TYR A 451 TRP A 454 THR A 455 ILE A 458 PHE A 494	None None ZN A 1 (-2.5A) None None None None None None None	0.60A	1xoqB-2qymA: 43.4	1xoqB-2qymA: 82.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	7 / 12	TYR A 281 HIS A 282 MET A 395 ASP A 440 LEU A 441 PHE A 494 ILE A 498	None None None ZN A 1 (-2.5A) None None None	0.52A	1xosA-2qymA: 43.4	1xosA-2qymA: 75.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOT_A_VDNA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	7 / 12	TYR A 281 HIS A 282 MET A 395 LEU A 441 ILE A 458 PHE A 494 ILE A 498	None	0.67A	1xotA-2qymA: 43.3	1xotA-2qymA: 75.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	7 / 12	TYR A 281 HIS A 282 MET A 395 LEU A 441 ASN A 443 ILE A 458 PHE A 494	None	0.58A	1xotB-2qymA: 43.3	1xotB-2qymA: 75.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_A_EV1A1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	6 / 12	TYR A 281 HIS A 282 LEU A 441 ILE A 458 GLU A 461 PHE A 494	None	1.07A	2weyA-2qymA: 30.6	2weyA-2qymA: 28.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_A_EV1A1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	6 / 12	TYR A 281 HIS A 282 LEU A 441 ILE A 458 GLU A 461 PHE A 494	None	1.41A	2weyA-2qymA: 30.6	2weyA-2qymA: 28.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EL5_B_1UNB201_2 (PROTEASE)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 12	GLY A 225 ASP A 220 PRO A 301 THR A 300 VAL A 296	None	0.72A	3el5B-2qymA: undetectable	3el5B-2qymA: 14.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_A_ROFA901_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	9 / 12	TYR A 281 HIS A 282 MET A 395 ASN A 443 PRO A 444 TRP A 454 THR A 455 ILE A 458 PHE A 494	None	0.59A	3g4lA-2qymA: 43.1	3g4lA-2qymA: 83.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_A_ROFA901_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	9 / 12	TYR A 281 HIS A 282 MET A 395 ASN A 443 PRO A 444 TYR A 451 TRP A 454 THR A 455 PHE A 494	None	0.60A	3g4lA-2qymA: 43.1	3g4lA-2qymA: 83.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_A_ROFA901_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	3 / 3	ASP A 220 LEU A 226 GLN A 453	None	0.79A	3g4lA-2qymA: 43.1	3g4lA-2qymA: 83.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_B_ROFB902_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	10 / 12	TYR A 281 HIS A 282 MET A 395 ASP A 440 LEU A 441 PRO A 444 TRP A 454 THR A 455 ILE A 458 PHE A 494	None None None ZN A 1 (-2.5A) None None None None None None	0.55A	3g4lB-2qymA: 43.1	3g4lB-2qymA: 83.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_B_ROFB902_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 12	TYR A 281 PRO A 444 TRP A 454 THR A 455 MET A 459	None	0.96A	3g4lB-2qymA: 43.1	3g4lB-2qymA: 83.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_C_ROFC903_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	11 / 12	TYR A 281 HIS A 282 MET A 395 ASP A 440 LEU A 441 ASN A 443 PRO A 444 TYR A 451 TRP A 454 THR A 455 ILE A 458	None None None ZN A 1 (-2.5A) None None None None None None None	0.54A	3g4lC-2qymA: 43.5	3g4lC-2qymA: 83.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_D_ROFD904_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	9 / 12	TYR A 281 HIS A 282 MET A 395 ASP A 440 LEU A 441 PRO A 444 TRP A 454 THR A 455 ILE A 458	None None None ZN A 1 (-2.5A) None None None None None	0.49A	3g4lD-2qymA: 44.9	3g4lD-2qymA: 83.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_D_ROFD904_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	6 / 12	TYR A 281 PRO A 444 TRP A 454 THR A 455 ILE A 458 MET A 459	None	0.97A	3g4lD-2qymA: 44.9	3g4lD-2qymA: 83.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IA4_C_MTXC164_1 (DIHYDROFOLATE REDUCTASE)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 12	ALA A 315 LEU A 382 PHE A 317 ILE A 370 LEU A 363	None	1.28A	3ia4C-2qymA: undetectable	3ia4C-2qymA: 14.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IAK_A_EV1A415_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 9	TYR A 281 ASN A 443 ILE A 458 PHE A 494 ILE A 498	None	0.65A	3iakA-2qymA: 43.1	3iakA-2qymA: 82.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IAK_A_EV1A415_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 9	TYR A 281 MET A 395 ASN A 443 ILE A 458 PHE A 494	None	0.67A	3iakA-2qymA: 43.1	3iakA-2qymA: 82.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MNO_A_DEXA784_2 (GLUCOCORTICOID RECEPTOR)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	4 / 6	MET A 408 LEU A 405 MET A 399 GLN A 430	None	1.19A	3mnoA-2qymA: 3.5	3mnoA-2qymA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MNP_A_DEXA784_2 (GLUCOCORTICOID RECEPTOR)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	4 / 6	MET A 408 LEU A 405 MET A 399 GLN A 430	None	1.21A	3mnpA-2qymA: 3.4	3mnpA-2qymA: 21.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TVX_A_PNXA902_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	7 / 9	TYR A 281 LEU A 441 ASN A 443 PRO A 444 THR A 455 ILE A 458 PHE A 494	None	0.73A	3tvxA-2qymA: 45.4	3tvxA-2qymA: 83.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TVX_B_PNXB902_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	4 / 7	TYR A 281 ASN A 443 ILE A 458 PHE A 494	None	0.57A	3tvxB-2qymA: 45.2	3tvxB-2qymA: 83.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JBT_A_ASDA501_1 (CYTOCHROME P450 MONOOXYGENASE)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 12	PHE A 248 ALA A 314 ALA A 315 THR A 294 VAL A 290	None	1.11A	4jbtA-2qymA: undetectable	4jbtA-2qymA: 25.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JBT_B_ASDB502_1 (CYTOCHROME P450 MONOOXYGENASE)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 11	PHE A 248 ALA A 314 ALA A 315 THR A 294 VAL A 290	None	1.11A	4jbtB-2qymA: undetectable	4jbtB-2qymA: 25.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QTU_D_SAMD301_1 (PUTATIVE METHYLTRANSFERASE BUD23)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	4 / 5	GLN A 378 LEU A 382 SER A 381 ASP A 423	None	1.20A	4qtuD-2qymA: undetectable	4qtuD-2qymA: 18.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UUU_A_SAMA1546_0 (CYSTATHIONINE BETA-SYNTHASE)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 11	LEU A 316 ALA A 291 HIS A 355 VAL A 436 ILE A 387	None	1.30A	4uuuA-2qymA: undetectable 4uuuB-2qymA: undetectable	4uuuA-2qymA: 17.96 4uuuB-2qymA: 17.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YOA_A_017A100_1 (HIV-1 PROTEASE)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	4 / 6	ASP A 220 PRO A 301 THR A 300 VAL A 296	None	0.85A	4yoaA-2qymA: undetectable	4yoaA-2qymA: 13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFIC LECTIN)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 8	GLU A 461 VAL A 279 HIS A 282 ASP A 323 HIS A 355	None None None MG A 2 ( 2.6A) None	1.22A	5f8yA-2qymA: undetectable	5f8yA-2qymA: 14.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFIC LECTIN)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 8	GLU A 461 VAL A 279 HIS A 282 ASP A 323 HIS A 355	None None None MG A 2 ( 2.6A) None	1.24A	5f8yB-2qymA: undetectable	5f8yB-2qymA: 14.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6H1L_B_FJQB501_0 (BIFUNCTIONAL CYTOCHROME P450/NADPH--P450 REDUCTASE)	2qym	PHOSPHODIESTERASE 4C (Homo sapiens)	5 / 11	LEU A 405 VAL A 409 THR A 505 ALA A 514 THR A 300	None	1.28A	6h1lB-2qymA: undetectable	6h1lB-2qymA: 21.46

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1FAP_A_RAPA108_2","FK506-BINDING PROTEIN;FRAP","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",4,"LEU A 234;ARG A 238;PHE A 204;GLY A 205","None","0.87A","1fapB-2qymA:undetectable","1fapB-2qymA:16.42"],["1G5Y_B_9CRB501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"ILE A 243;ALA A 291;LEU A 298;LEU A 253;ILE A 247","None","1.24A","1g5yB-2qymA:undetectable","1g5yB-2qymA:25.27"],["1GSE_A_EAAA224_1","GLUTATHIONE TRANSFERASE","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"ARG A 251;LEU A 313;LEU A 382;VAL A 386;ALA A 320","None","0.97A","1gseA-2qymA:undetectable","1gseA-2qymA:22.46"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"TYR A 281;ASN A 443;THR A 455;ILE A 458;MET A 459","None","0.81A","1xlxA-2qymA:43.2","1xlxA-2qymA:75.78"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",9,"TYR A 281;HIS A 282;HIS A 326;MET A 395;LEU A 441;ASN A 443;THR A 455;ILE A 458;PHE A 494","None","0.50A","1xlxA-2qymA:43.2","1xlxA-2qymA:75.78"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",7,"TYR A 281;HIS A 282;HIS A 326;MET A 395;THR A 455;ILE A 458;PHE A 494","None","0.47A","1xlxB-2qymA:43.4","1xlxB-2qymA:75.78"],["1XMU_A_ROFA101_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",9,"TYR A 281;HIS A 282;ASP A 440;LEU A 441;PRO A 444;TYR A 451;TRP A 454;ILE A 458;PHE A 494","None;None; ZN A   1 (-2.5A);None;None;None;None;None;None","0.59A","1xmuA-2qymA:44.0","1xmuA-2qymA:75.78"],["1XMU_B_ROFB102_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",9,"TYR A 281;HIS A 282;MET A 395;ASP A 440;LEU A 441;PRO A 444;TYR A 451;TRP A 454;ILE A 458","None;None;None; ZN A   1 (-2.5A);None;None;None;None;None","0.54A","1xmuB-2qymA:43.4","1xmuB-2qymA:75.78"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",7,"TYR A 281;HIS A 282;MET A 395;ASP A 440;LEU A 441;ILE A 458;PHE A 494","None;None;None; ZN A   1 (-2.5A);None;None;None","0.44A","1xomA-2qymA:43.7","1xomA-2qymA:82.52"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",7,"TYR A 281;HIS A 282;MET A 395;LEU A 441;THR A 455;ILE A 458;PHE A 494","None","0.46A","1xomB-2qymA:43.6","1xomB-2qymA:82.52"],["1XOQ_A_ROFA502_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",10,"TYR A 281;HIS A 282;MET A 395;ASP A 440;LEU A 441;PRO A 444;TYR A 451;THR A 455;ILE A 458;PHE A 494","None;None;None; ZN A   1 (-2.5A);None;None;None;None;None;None","0.60A","1xoqA-2qymA:43.9","1xoqA-2qymA:82.52"],["1XOQ_B_ROFB501_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",10,"TYR A 281;HIS A 282;ASP A 440;LEU A 441;PRO A 444;TYR A 451;TRP A 454;THR A 455;ILE A 458;PHE A 494","None;None; ZN A   1 (-2.5A);None;None;None;None;None;None;None","0.60A","1xoqB-2qymA:43.4","1xoqB-2qymA:82.52"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",7,"TYR A 281;HIS A 282;MET A 395;ASP A 440;LEU A 441;PHE A 494;ILE A 498","None;None;None; ZN A   1 (-2.5A);None;None;None","0.52A","1xosA-2qymA:43.4","1xosA-2qymA:75.78"],["1XOT_A_VDNA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",7,"TYR A 281;HIS A 282;MET A 395;LEU A 441;ILE A 458;PHE A 494;ILE A 498","None","0.67A","1xotA-2qymA:43.3","1xotA-2qymA:75.78"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",7,"TYR A 281;HIS A 282;MET A 395;LEU A 441;ASN A 443;ILE A 458;PHE A 494","None","0.58A","1xotB-2qymA:43.3","1xotB-2qymA:75.78"],["2WEY_A_EV1A1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",6,"TYR A 281;HIS A 282;LEU A 441;ILE A 458;GLU A 461;PHE A 494","None","1.07A","2weyA-2qymA:30.6","2weyA-2qymA:28.87"],["2WEY_A_EV1A1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",6,"TYR A 281;HIS A 282;LEU A 441;ILE A 458;GLU A 461;PHE A 494","None","1.41A","2weyA-2qymA:30.6","2weyA-2qymA:28.87"],["3EL5_B_1UNB201_2","PROTEASE","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"GLY A 225;ASP A 220;PRO A 301;THR A 300;VAL A 296","None","0.72A","3el5B-2qymA:undetectable","3el5B-2qymA:14.89"],["3G4L_A_ROFA901_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",9,"TYR A 281;HIS A 282;MET A 395;ASN A 443;PRO A 444;TRP A 454;THR A 455;ILE A 458;PHE A 494","None","0.59A","3g4lA-2qymA:43.1","3g4lA-2qymA:83.20"],["3G4L_A_ROFA901_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",9,"TYR A 281;HIS A 282;MET A 395;ASN A 443;PRO A 444;TYR A 451;TRP A 454;THR A 455;PHE A 494","None","0.60A","3g4lA-2qymA:43.1","3g4lA-2qymA:83.20"],["3G4L_A_ROFA901_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",3,"ASP A 220;LEU A 226;GLN A 453","None","0.79A","3g4lA-2qymA:43.1","3g4lA-2qymA:83.20"],["3G4L_B_ROFB902_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",10,"TYR A 281;HIS A 282;MET A 395;ASP A 440;LEU A 441;PRO A 444;TRP A 454;THR A 455;ILE A 458;PHE A 494","None;None;None; ZN A   1 (-2.5A);None;None;None;None;None;None","0.55A","3g4lB-2qymA:43.1","3g4lB-2qymA:83.20"],["3G4L_B_ROFB902_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"TYR A 281;PRO A 444;TRP A 454;THR A 455;MET A 459","None","0.96A","3g4lB-2qymA:43.1","3g4lB-2qymA:83.20"],["3G4L_C_ROFC903_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",11,"TYR A 281;HIS A 282;MET A 395;ASP A 440;LEU A 441;ASN A 443;PRO A 444;TYR A 451;TRP A 454;THR A 455;ILE A 458","None;None;None; ZN A   1 (-2.5A);None;None;None;None;None;None;None","0.54A","3g4lC-2qymA:43.5","3g4lC-2qymA:83.20"],["3G4L_D_ROFD904_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",9,"TYR A 281;HIS A 282;MET A 395;ASP A 440;LEU A 441;PRO A 444;TRP A 454;THR A 455;ILE A 458","None;None;None; ZN A   1 (-2.5A);None;None;None;None;None","0.49A","3g4lD-2qymA:44.9","3g4lD-2qymA:83.20"],["3G4L_D_ROFD904_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",6,"TYR A 281;PRO A 444;TRP A 454;THR A 455;ILE A 458;MET A 459","None","0.97A","3g4lD-2qymA:44.9","3g4lD-2qymA:83.20"],["3IA4_C_MTXC164_1","DIHYDROFOLATE REDUCTASE","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"ALA A 315;LEU A 382;PHE A 317;ILE A 370;LEU A 363","None","1.28A","3ia4C-2qymA:undetectable","3ia4C-2qymA:14.25"],["3IAK_A_EV1A415_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"TYR A 281;ASN A 443;ILE A 458;PHE A 494;ILE A 498","None","0.65A","3iakA-2qymA:43.1","3iakA-2qymA:82.52"],["3IAK_A_EV1A415_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"TYR A 281;MET A 395;ASN A 443;ILE A 458;PHE A 494","None","0.67A","3iakA-2qymA:43.1","3iakA-2qymA:82.52"],["3MNO_A_DEXA784_2","GLUCOCORTICOID RECEPTOR","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",4,"MET A 408;LEU A 405;MET A 399;GLN A 430","None","1.19A","3mnoA-2qymA:3.5","3mnoA-2qymA:21.64"],["3MNP_A_DEXA784_2","GLUCOCORTICOID RECEPTOR","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",4,"MET A 408;LEU A 405;MET A 399;GLN A 430","None","1.21A","3mnpA-2qymA:3.4","3mnpA-2qymA:21.64"],["3TVX_A_PNXA902_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",7,"TYR A 281;LEU A 441;ASN A 443;PRO A 444;THR A 455;ILE A 458;PHE A 494","None","0.73A","3tvxA-2qymA:45.4","3tvxA-2qymA:83.88"],["3TVX_B_PNXB902_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",4,"TYR A 281;ASN A 443;ILE A 458;PHE A 494","None","0.57A","3tvxB-2qymA:45.2","3tvxB-2qymA:83.88"],["4JBT_A_ASDA501_1","CYTOCHROME P450 MONOOXYGENASE","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"PHE A 248;ALA A 314;ALA A 315;THR A 294;VAL A 290","None","1.11A","4jbtA-2qymA:undetectable","4jbtA-2qymA:25.91"],["4JBT_B_ASDB502_1","CYTOCHROME P450 MONOOXYGENASE","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"PHE A 248;ALA A 314;ALA A 315;THR A 294;VAL A 290","None","1.11A","4jbtB-2qymA:undetectable","4jbtB-2qymA:25.91"],["4QTU_D_SAMD301_1","PUTATIVE METHYLTRANSFERASE BUD23","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",4,"GLN A 378;LEU A 382;SER A 381;ASP A 423","None","1.20A","4qtuD-2qymA:undetectable","4qtuD-2qymA:18.61"],["4UUU_A_SAMA1546_0","CYSTATHIONINE BETA-SYNTHASE","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"LEU A 316;ALA A 291;HIS A 355;VAL A 436;ILE A 387","None","1.30A","4uuuA-2qymA:undetectable;4uuuB-2qymA:undetectable","4uuuA-2qymA:17.96;4uuuB-2qymA:17.96"],["4YOA_A_017A100_1","HIV-1 PROTEASE","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",4,"ASP A 220;PRO A 301;THR A 300;VAL A 296","None","0.85A","4yoaA-2qymA:undetectable","4yoaA-2qymA:13.76"],["5F8Y_A_X6XA202_1","GALNAC\/GAL-SPECIFIC LECTIN","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"GLU A 461;VAL A 279;HIS A 282;ASP A 323;HIS A 355","None;None;None; MG A   2 ( 2.6A);None","1.22A","5f8yA-2qymA:undetectable","5f8yA-2qymA:14.64"],["5F8Y_B_X6XB201_1","GALNAC\/GAL-SPECIFIC LECTIN","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"GLU A 461;VAL A 279;HIS A 282;ASP A 323;HIS A 355","None;None;None; MG A   2 ( 2.6A);None","1.24A","5f8yB-2qymA:undetectable","5f8yB-2qymA:14.64"],["6H1L_B_FJQB501_0","BIFUNCTIONAL CYTOCHROME P450\/NADPH--P450 REDUCTASE","2qym","PHOSPHODIESTERASE 4C","Homo sapiens",5,"LEU A 405;VAL A 409;THR A 505;ALA A 514;THR A 300","None","1.28A","6h1lB-2qymA:undetectable","6h1lB-2qymA:21.46"]]